Search Results
You are looking at 1-1 of 1
Masaharu YamadaDDS,
Masataka TamuraDDS, PhD,
Yoko NunotaniDDS,
Nobumasa MinamiDDS, and
Kikuo FujiDDS, PhD
Article Category: Brief Report
Volume/Issue: Volume 69: Issue 3
Online Publication Date: Oct 06, 2022
Page Range: 36 – 37
substantial risk of perioperative complications, including spinal fracture and neurological injury. His temporomandibular joint movement range was normal, and his mouth opening was ∼5 cm. Preoperative pulmonary function tests showed a slight reduction in vital capacity (77.7% of predicted), indicating mild restrictive ventilatory impairment. He received intravenous infliximab every 8 weeks, and his daily medications were prednisolone (7 mg), salazosulfapyridine (sulfasalazine; 1000 mg), loxoprofen (180 mg), and esomeprazole for acid reflux.
Before the operation, the